Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

Go back to Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
(NASDAQ: AMLX) Delayed: 33.88 -0.22 (0.65%)
Previous Close $34.10    52 Week High
Open $33.49    52 Week Low
Day High $34.72    P/E N/A 
Day Low $33.10    EPS
Volume 1,166,470